GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

A new study is challenging one of neuroscience’s most enduring ideas: that the brain’s reward system exists to make us feel good. Instead, researchers argue that it is built to optimize energy.

Scientists say they've uncovered striking new evidence of how alcohol addiction impacts the brain's learning systems—and how those systems may slowly adapt during recovery—in a new study published in ...

Research by the Technion has demonstrated that activation of the brain's reward system could boost recovery from a heart attack. The research, which was conducted at the Ruth and Bruce Rappaport ...

When faced with multiple food options and ultimately choosing one, the factors of that decision-making process may be more physiological than previously assumed. A group of scientists led by ...

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite—it directly alters brain circuits that control motivation and reward.

Scientists are rethinking how depression should be treated by focusing less on reducing negative feelings and more on rebuilding the brain’s capacity for positive emotion.